Ferhat Ekinci

30PUBLICATIONS
148CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEnvironmental studies in animal productionInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Oct 26, 2026
Lactate Dehydrogenase-to-Albumin Ratio and Glasgow Prognostic Score as Prognostic Markers in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.

|Oct 23, 2026
Biological frailty and chemotherapy dose intensity independently predict survival in older adults with Stage II-III colon cancer.

|Aug 27, 2026
Comparison of 24 Versus 46-Hour 5-FU Infusion Durations in the Perioperative FLOT Therapy for Gastric Cancer.

|Aug 13, 2026
Outcomes and Prognostic Factors of Cetuximab-Based Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

|Jul 15, 2026
Real-World Treatment Outcomes After Nivolumab Progression in BRAF-Negative Metastatic Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group.

|Jul 15, 2026
Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study.

Pageof 5

Frequent Collaborators

19 joint publications

Atike Pınar Erdoğan

11 joint publications

Mustafa Sahbazlar

6 joint publications

Ahmet Burak Agaoglu

4 joint publications

Tugay Avci